Some reports even correlate ESR1 mutations with changes in the tumor microenvironment, such as increased angiogenesis, altered cell adhesion, and changes in immune evasion mechanisms, all leading to metastatic proliferation [26,27]. This evidence concerns the gene ESR1 and neoplasm.